Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹214
PTR :
₹163.05
PTS :
₹146.74
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Made by Vibcare Pharma, Viglim M4 is an oral tablet with Glimepiride 4 mg and Metformin 500 mg as its active ingredients. It is a sulfonylurea and biguanide antidiabetic combination, packed as 10x15 (Blister) in Vibcare Pharma's Cure division.
Glimepiride acts on the pancreas and prompts the release of insulin, which carries glucose out of the blood. Metformin, from the biguanide group, lowers the glucose released by the liver and helps the body use the insulin available.
The tablets are used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. They carry two serious risks: glimepiride may cause severe hypoglycemia, and metformin may rarely cause lactic acidosis, with muscle pain, breathing difficulty, sleepiness and abdominal pain as warning signs.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Viglim M4 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare
Viglim M4 tablets provide Glimepiride 4 mg and Metformin 500 mg as an addition to diet and exercise in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; lowers raised blood sugar in adults with type 2 diabetes when diet and exercise alone are not enough; used as one part of the diabetes care plan set by the treating doctor.
Common side effects of Viglim M4 Tablet include low blood sugar (hypoglycemia); headache; dizziness; nausea; weakness or tiredness; diarrhoea and stomach discomfort. Get medical help at once if you notice severe hypoglycemia; lactic acidosis (rare but serious, linked to metformin; symptoms include muscle pain, breathing difficulty, sleepiness and abdominal pain); hemolytic anemia in patients with G6PD deficiency.
Each Viglim M4 tablet contains Glimepiride 4 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim M4 Tablet only as your doctor advises.
The MRP of Viglim M4 Tablet is ₹214 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹163.05 and the PTS is ₹146.74.
Each Viglim M4 tablet contains Glimepiride 4 mg + Metformin 500 mg. It comes in a pack of 10x15 (Blister).
Glimepiride acts on the pancreas and prompts the release of insulin, which carries glucose out of the blood. Metformin, from the biguanide group, lowers the glucose released by the liver and helps the body use the insulin available.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used by patients with severe kidney impairment or any metabolic acidosis. Must not be used by patients allergic to glimepiride, metformin or sulfonamide derivatives. Check with a doctor first if you have reduced kidney or liver function, are 65 years or older, or drink alcohol heavily (these raise the risk of lactic acidosis with metformin). Check with a doctor first if you are pregnant, planning pregnancy or breastfeeding.
Viglim M4 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner